EUVIMEDEUVIMED entdecken
Vergleichsstudie

Small bowel neuroendocrine tumors: Unique features and low lethality compared with small bowel adenocarcinoma

Zhen Yang iD, Haibin Xu, Luan Li, Kaiming Leng, Guangjun Shi

Journal of Gastroenterology and Hepatology · 2024

DOI: 10.1111/jgh.16740 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Gastroenterology and Hepatology, 2024. Verfasst von Zhen Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatopancreatobiliary Surgery, Qingdao Municipal Hospital, Qingdao University, Qingdao, China. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Adenocarcinoma, Intestinal Neoplasms, Intestine, Small. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim Population‐based studies comparing clinical characteristics and survival disparities between patients with small bowel adenocarcinoma (SBA) and small bowel neuroendocrine tumors (SBNETs) in the United States are limited.

Methods

Data for patients with SBA or SBNETs, obtained from the Surveillance, Epidemiology, and End Results database for the years between 2000 and 2018 were analyzed.

Results

Between 2000 and 2018, the age‐adjusted incidence of SBA experienced a marginal increase whereas SBNETs demonstrated a significant increase, emerging as the predominant subtype of small bowel cancer (SBC). Diagnoses peaked at ages 65–69 years for SBA and 60–64 years for SBNETs, with the latter exhibiting a heightened age‐specific incidence and maintaining equilibrium in gender distribution. Clinicopathologic disparities revealed SBA's duodenal predilection, larger tumor size, and advanced stages, contrasting with SBNETs' ileal predilection, early‐stage presentation, and superior outcomes. SBNETs patients underwent surgery more frequently but received less chemotherapy and radiation than SBA patients. Factors intricately correlated with a diagnosis of SBNETs included female gender, White race, advanced age, marital status, recent diagnoses, superior tumor differentiation, smaller size, distal location, and early‐stage presentation. Survival analysis unveiled a remarkable 79% reduction in the mortality risk for SBNETs compared with SBA. Subgroup analysis further confirmed the consistently favorable survival advantages of SBNETs, highlighting the clinical relevance of histological classification in prognostication.

Conclusion

Compared with SBA, SBNETs exhibited distinctive clinicopathological features characterized by a higher inclination toward low‐grade and early‐stage manifestations, thereby contributing to superior survival outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsAdenocarcinomaIntestinal NeoplasmsIntestine, SmallHumansMiddle AgedMaleFemaleAgedUnited StatesSEER ProgramIncidenceAge FactorsSex FactorsAdultNeoplasm StagingSurvival RateIleal Neoplasms

Stichwörter der Autor:innen

Clinical characteristicsEpidemiologySmall bowel adenocarcinomaSmall bowel cancerSmall bowel neuroendocrine tumorsSurvival

Autor:innen und Institutionen

  • Department of Hepatopancreatobiliary Surgery, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.
  • Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), China.
  • Department of radiology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), China.

ORCID-Profile: Zhen Yang

Zitieren

APA

Yang, Z., Xu, H., Li, L., Leng, K., & Shi, G. (2024). Small bowel neuroendocrine tumors: Unique features and low lethality compared with small bowel adenocarcinoma. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16740

Vancouver

Yang Z, Xu H, Li L, Leng K, Shi G. Small bowel neuroendocrine tumors: Unique features and low lethality compared with small bowel adenocarcinoma. Journal of Gastroenterology and Hepatology. 2024. doi:10.1111/jgh.16740

BibTeX
@article{Yang2024,
  author = {Yang, Zhen and Xu, Haibin and Li, Luan and Leng, Kaiming and Shi, Guangjun},
  title = {Small bowel neuroendocrine tumors: Unique features and low lethality compared with small bowel adenocarcinoma},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2024},
  doi = {10.1111/jgh.16740}
}
Kostenlos starten →